Stonebrook Private Inc. Compass Therapeutics, Inc. Transaction History
Stonebrook Private Inc.
- $385 Billion
- Q1 2025
A detailed history of Stonebrook Private Inc. transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Stonebrook Private Inc. holds 12,294 shares of CMPX stock, worth $33,193. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,294
Previous 11,288
8.91%
Holding current value
$33,193
Previous $16.4 Million
42.71%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
121Shares Held
99.9MCall Options Held
2.52MPut Options Held
3.1M-
Orbimed Advisors LLC San Diego, CA22.4MShares$60.4 Million1.32% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$29.8 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$27.1 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$22.8 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$17.9 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $273M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...